Got CKD? There's an App for That!

Clin J Am Soc Nephrol

Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Published: April 2019

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450351PMC
http://dx.doi.org/10.2215/CJN.02350219DOI Listing

Publication Analysis

Top Keywords

ckd? there's
4
there's app
4
app that!
4
ckd?
1
app
1
that!
1

Similar Publications

All-cause mortality and factors associated with it in Finnish patients with type 1 diabetes.

J Diabetes Complications

December 2024

Tampere University, Faculty of Medicine and Health Technology, Tampere, Finland; Tampere University Hospital, Department of Internal Medicine, Tampere, Finland.

Aims: To assess the effect of comorbidities, risk classification for chronic kidney disease (CKD) according to albuminuria and eGFR, HbA1c and LDL-cholesterol levels on all-cause mortality in patients with type 1 diabetes (DM1).

Methods: The study included all 45,801 DM1 patients from the Finnish Diabetes Registry during 2018-2022. Mortality of patients with DM1 was compared with mortality in non-diabetic population in Finland by estimating standardized mortality rates (SMRs).

View Article and Find Full Text PDF

Background: Non-communicable diseases (NCDs) pose a significant global health challenge, constituting over 80% of mortality and morbidity. This burden is particularly pronounced in low- and middle-income countries (LMICs), including Ethiopia. Despite this, there's limited research on this issue in Africa.

View Article and Find Full Text PDF

Introduction Renal failure, comprising acute kidney injury (AKI) and chronic kidney disease (CKD), involves a decline or loss of kidney function. AKI is sudden and reversible, with a rapid decline in function over hours to days, while CKD involves persistent abnormalities lasting at least three months. Developing countries are seeing a rise in AKI cases, especially in critically ill patients.

View Article and Find Full Text PDF

Determinants of early chronic kidney disease in patients with recently diagnosed type 2 diabetes mellitus: a retrospective study from the Taiwan Diabetes Registry.

BMC Nephrol

April 2024

Section of Endocrinology and Metabolism, Department of Internal Medicine, Ditmanson Medical Foundation, Chiayi Christian Hospital, No. 539 Jhongsiao Rd., Chia-Yi City, 600, Taiwan R.O.C..

Article Synopsis
  • The study aimed to find risk factors linked to early chronic kidney disease (CKD) in newly diagnosed type 2 diabetes patients using data from the Taiwan Diabetes Registry.
  • The research involved 2,217 patients, categorizing them into an early CKD group and a control group, and utilized logistic regression to analyze clinical characteristics and linear regression for predicting kidney function indicators.
  • Key risk factors identified included age, systolic blood pressure, glycated hemoglobin, and triglycerides, with a noted bidirectional relationship between urine-albumin to creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR).
View Article and Find Full Text PDF

Hypoxia inducible factor prolyl hydroxylase inhibitors: what a meta-analysis could tell us.

Clin Kidney J

January 2024

Renal Research Institute, New York, USA, Institute of Biology and Molecular Biology (BIOGEM), Ariano Irpino, Italy and IPNET, Reggio Calabria, Italy.

Meta-analyses offer an estimate of the overall effect size and help address the inconsistency in findings across studies. The risk is the overemphasis on statistical significance while underrepresenting or misinterpreting clinical significance. There's also a lack of standardized methods for quantifying and reporting clinical significance and these measures are often missing or inconsistently reported in many meta-analyses, making it difficult for readers to determine the clinical relevance of the findings.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!